Warning Letter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

An FDA post-audit letter notifying the manufacture of adverse inspections findings requiring a reply with defined plans for remediation.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters